125
Views
0
CrossRef citations to date
0
Altmetric
SHORT REPORT

Identification of a Multidrug Resistant Pseudomonas aeruginosa Isolate Harboring Infrequent Red Fluorescence Plasmid from COPD Patient

, , , , , & show all
Pages 7301-7305 | Received 02 Aug 2022, Accepted 01 Dec 2022, Published online: 13 Dec 2022

References

  • Rabe KF, Watz H. Chronic obstructive pulmonary disease. Lancet. 2017;389:1931–1940. doi:10.1016/S0140-6736(17)31222-9
  • WHO. World Health Organization website; 2021. Available from: http://www.who.int. Accessed December 5, 2022.
  • GOLD. Global initiative for chronic obstructive lung disease. global strategy for diagnosis, management and prevention of chronic pulmonary obstructive disease 2022 report. Available from: https://goldcopd.org/2022-gold-reports-2/. Accessed December 5, 2022.
  • Soriano JB, Kendrick PJ, Paulson KR. Prevalence and attributable health burden of chronic respiratory diseases, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet Respir Med. 2020;8:585–596. doi:10.1016/S2213-2600(20)30105-3
  • Negewo NA, Gibson PG, McDonald VM. COPD and its comorbidities: impact, measurement and mechanisms. Respirology. 2015;20:1160–1171. doi:10.1111/resp.12642
  • Rogliani P, Ritondo BL, Laitano R, et al. Advances in understanding of mechanisms related to increased cardiovascular risk in COPD. Expert Rev Respir Med. 2021;15:59–70. doi:10.1080/17476348.2021.1840982
  • Cavallazzi R, Ramirez J. Community-acquired pneumonia in chronic obstructive pulmonary disease. Curr Opin Infect Dis. 2020;33:173–181. doi:10.1097/QCO.0000000000000639
  • Labaki WW, Rosenberg SR. Chronic obstructive pulmonary disease. Ann Intern Med. 2020;173:ITC17–ITC32. doi:10.7326/AITC202008040
  • Restrepo MI, Babu BL, Reyes LF, et al. Burden and risk factors for Pseudomonas aeruginosa community-acquired pneumonia: a multinational point prevalence study of hospitalised patients. Eur Respir J. 2018;52:1701190. doi:10.1183/13993003.01190-2017
  • Thu PNT, Huong MNT, Thi NT, et al. Combination antibiotic therapy versus monotherapy in the treatment of acute exacerbations of chronic obstructive pulmonary disease: an open-label randomized trial. BMC Infect Dis. 2021;21:1019. doi:10.1186/s12879-021-06687-3
  • Stover CK, Pham XQ, Erwin AL, et al. Complete genome sequence of Pseudomonas aeruginosa PAO1, an opportunistic pathogen. Nature. 2000;406:959–964. doi:10.1038/35023079
  • Balasubramanian D, Schneper L, Kumari H, Mathee K. A dynamic and intricate regulatory network determines Pseudomonas aeruginosa virulence. Nucleic Acids Res. 2013;41:1–20. doi:10.1093/nar/gks1039
  • Zhao K, Li W, Li J, et al. TesG is a type I secretion effector of Pseudomonas aeruginosa that suppresses the host immune response during chronic infection. Nat Microbiol. 2019;4:459–469. doi:10.1038/s41564-018-0322-4
  • World Health Organization. Global priority list of antibiotic-resistant bacteria to guide research, discovery, and development of new antibiotics; 2017. Available from: http://www.who.int/medicines/publications/global-priority-list-.antibiotic-resistant-bacteria/en/. Accessed December 5, 2022.
  • Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing: 25th informational supplement. In: CLSI Document. Clinical and Laboratory Standards Institute; 2015:M100–S25.
  • Zhao K, Huang T, Lin J, et al. Genetic and functional diversity of Pseudomonas aeruginosa in patients with chronic obstructive pulmonary disease. Front Microbiol. 2020;11:598478. doi:10.3389/fmicb.2020.598478
  • Fang J, Jiao X, Cheng H, et al. Draft genome of a multidrug and multi-heavy metal resistant Vibrio parahaemolyticus ST165 strain of Penaeus vannamei from seawater farms in Zhejiang, China. J Glob Antimicrob Resist. 2021;26:323–325. doi:10.1016/j.jgar.2021.07.015
  • Stanisich VA, Bennett PM, Richmond MH. Characterization of a translocation unit encoding resistance to mercuric ions that occurs on a nonconjugative plasmid in Pseudomonas aeruginosa. J Bacteriol. 1977;129:1227–1233. doi:10.1128/jb.129.3.1227-1233.1977